Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.

Shahabi V, Maciag PC, Rivera S, Wallecha A.

Bioeng Bugs. 2010 Jul-Aug;1(4):235-43. doi: 10.4161/bbug.1.4.11243. Epub 2010 Jan 4. Review.

PMID:
21327055
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Bacterial systems for the delivery of eukaryotic antigen expression vectors.

Dietrich G, Spreng S, Gentschev I, Goebel W.

Antisense Nucleic Acid Drug Dev. 2000 Oct;10(5):391-9. Review.

PMID:
11079578
[PubMed - indexed for MEDLINE]
3.

Listeria-based vaccines for cancer treatment.

Paterson Y, Maciag PC.

Curr Opin Mol Ther. 2005 Oct;7(5):454-60. Review.

PMID:
16248280
[PubMed - indexed for MEDLINE]
4.

Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella.

Verma NK, Ziegler HK, Wilson M, Khan M, Safley S, Stocker BA, Schoolnik GK.

Vaccine. 1995 Feb;13(2):142-50.

PMID:
7625107
[PubMed - indexed for MEDLINE]
5.

Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.

Singh R, Paterson Y.

Expert Rev Vaccines. 2006 Aug;5(4):541-52. Review.

PMID:
16989634
[PubMed - indexed for MEDLINE]
6.

Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.

Wood LM, Paterson Y.

Front Cell Infect Microbiol. 2014 May 12;4:51. doi: 10.3389/fcimb.2014.00051. eCollection 2014. Review.

PMID:
24860789
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.

Weiskirch LM, Paterson Y.

Immunol Rev. 1997 Aug;158:159-69. Review.

PMID:
9314084
[PubMed - indexed for MEDLINE]
8.

Bacterial carriers and virus-like-particles as antigen delivery devices: role of dendritic cells in antigen presentation.

Beyer T, Herrmann M, Reiser C, Bertling W, Hess J.

Curr Drug Targets Infect Disord. 2001 Nov;1(3):287-302. Review.

PMID:
12455402
[PubMed - indexed for MEDLINE]
9.

From evil to good: a cytolysin in vaccine development.

Dietrich G, Hess J, Gentschev I, Knapp B, Kaufmann SH, Goebel W.

Trends Microbiol. 2001 Jan;9(1):23-8. Review.

PMID:
11166239
[PubMed - indexed for MEDLINE]
10.

Recent advances in the development of live, attenuated bacterial vectors.

Roland KL, Tinge SA, Killeen KP, Kochi SK.

Curr Opin Mol Ther. 2005 Feb;7(1):62-72. Review.

PMID:
15732531
[PubMed - indexed for MEDLINE]
11.

Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.

Brockstedt DG, Dubensky TW.

Expert Rev Vaccines. 2008 Sep;7(7):1069-84. doi: 10.1586/14760584.7.7.1069. Review.

PMID:
18767955
[PubMed - indexed for MEDLINE]
12.

What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors.

Hussain SF, Paterson Y.

Cancer Immunol Immunother. 2005 Jun;54(6):577-86. Epub 2005 Jan 14.

PMID:
15650885
[PubMed - indexed for MEDLINE]
13.

Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.

Svensson M, Pfeifer J, Stockinger B, Wick MJ.

Behring Inst Mitt. 1997 Feb;(98):197-211. Review.

PMID:
9382741
[PubMed - indexed for MEDLINE]
14.

[Therapeutic intervention alternatives in cancer, using attenuated live bacterial vectors: Salmonella enterica as a carrier of heterologous molecules].

Hernández-Luna MA, Luria-Pérez R, Huerta-Yépez S.

Rev Invest Clin. 2013 Jan-Feb;65(1):65-73. Review. Spanish.

PMID:
23745445
[PubMed - indexed for MEDLINE]
15.

Tumor antigen delivered by Salmonella III secretion protein fused with heat shock protein 70 induces protection and eradication against murine melanoma.

Zhu X, Zhou P, Cai J, Yang G, Liang S, Ren D.

Cancer Sci. 2010 Dec;101(12):2621-8. doi: 10.1111/j.1349-7006.2010.01722.x. Epub 2010 Sep 30.

PMID:
20880334
[PubMed - indexed for MEDLINE]
16.

Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens.

Paterson Y, Johnson RS.

Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S119-34. Review.

PMID:
15285711
[PubMed - indexed for MEDLINE]
17.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Knutson KL, Disis ML.

Cancer Immunol Immunother. 2005 Aug;54(8):721-8. Epub 2005 Jan 27. Review.

PMID:
16010587
[PubMed - indexed for MEDLINE]
18.

Live-attenuated bacteria as a cancer vaccine vector.

Toussaint B, Chauchet X, Wang Y, Polack B, Le Gouëllec A.

Expert Rev Vaccines. 2013 Oct;12(10):1139-54. doi: 10.1586/14760584.2013.836914. Review.

PMID:
24124876
[PubMed - indexed for MEDLINE]
19.

Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system.

Xu X, Hegazy WA, Guo L, Gao X, Courtney AN, Kurbanov S, Liu D, Tian G, Manuel ER, Diamond DJ, Hensel M, Metelitsa LS.

Cancer Res. 2014 Nov 1;74(21):6260-70. doi: 10.1158/0008-5472.CAN-14-1169. Epub 2014 Sep 11.

PMID:
25213323
[PubMed - indexed for MEDLINE]
20.

Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.

Paterson Y, Guirnalda PD, Wood LM.

Semin Immunol. 2010 Jun;22(3):183-9. doi: 10.1016/j.smim.2010.02.002. Epub 2010 Mar 17. Review.

PMID:
20299242
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk